Lessee, Operating Lease, Liability, to be Paid, Year Four in USD of Galera Therapeutics, Inc. from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Galera Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q4 2018 to Q2 2024.
  • Galera Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 30 Jun 2024 was $633K, a 26.1% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

Galera Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $633K -$223K -26.1% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $633K 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $224K 31 Dec 2023 10-K 28 Mar 2024
Q3 2023 $857K 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $856K 30 Jun 2023 10-Q 14 Aug 2023
Q2 2020 $44K 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $44K 31 Mar 2020 10-Q 12 May 2020
Q4 2019 $44K -$347K -88.7% 31 Dec 2019 10-K 10 Mar 2020
Q3 2019 $262K 30 Sep 2019 10-Q 10 Dec 2019
Q4 2018 $391K 31 Dec 2018 10-Q 10 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.